Due to the current stagnation in the development of new treatments based on traditional drugs and mechanisms in neuroscience, the resurgence of psychedelics has opened up a rapidly expanding field of research that encompasses the study of consciousness, mental disorders, and their treatment. This project aims to bring together academic institutions from various research fields, the pharmaceutical industry, and organizations working on the reclassification of psychedelics.
Project funding:
EU COST Programme
Project results:
The goal is to create a psychedelic research platform that would create the prerequisites for developing large-scale collaborative projects, conducting multi-centre academic clinical trials on a European scale, ensuring open data sharing, using big data analytics, and creating conditions for the integration of psychedelics into mental health care.
Period of project implementation: 2025-10-30 - 2029-10-29
Project partners: Bosnia and Herzegovina, Czech Republic, Denmark, Estonia, Germany, Greece, Ireland, Israel, Lithuania, Malta, Poland, Portugal, Spain, Sweden, United Kingdom, Cyprus, France, Latvia, Croatia, Italy, Netherlands, North Macedonia
